Stricter requirements imposed by government regulators, a higher level of scrutiny by proxy advisory firms and an increasingly litigious plaintiff’s bar are making it harder to attract strong board members who meet the tests of independence and experience. In this article, the authors share several steps that biotech companies can take to make their boards more attractive to top-tier candidates.View full article, Attracting a Strong Board
